STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $19.85 billion. The enterprise value is $23.17 billion.
| Market Cap | 19.85B |
| Enterprise Value | 23.17B |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | Feb 22, 2024 |
Share Statistics
STERIS has 98.81 million shares outstanding. The number of shares has decreased by -1.02% in one year.
| Shares Outstanding | 98.81M |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 98.19% |
| Float | 98.45M |
Valuation Ratios
The trailing PE ratio is 35.25 and the forward PE ratio is 21.27. STERIS's PEG ratio is 6.88.
| PE Ratio | 35.25 |
| Forward PE | 21.27 |
| PS Ratio | 3.67 |
| Forward PS | 3.43 |
| PB Ratio | 3.09 |
| P/FCF Ratio | 32.88 |
| PEG Ratio | 6.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.63, with an EV/FCF ratio of 38.37.
| EV / Earnings | 40.87 |
| EV / Sales | 4.28 |
| EV / EBITDA | 16.63 |
| EV / EBIT | 28.24 |
| EV / FCF | 38.37 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.55.
| Current Ratio | 2.43 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 2.52 |
| Debt / FCF | 5.81 |
| Interest Coverage | 5.91 |
Financial Efficiency
Return on equity (ROE) is 9.10% and return on invested capital (ROIC) is 6.84%.
| Return on Equity (ROE) | 9.10% |
| Return on Assets (ROA) | 5.10% |
| Return on Capital (ROIC) | 6.84% |
| Revenue Per Employee | $316,221 |
| Profits Per Employee | $33,149 |
| Employee Count | 17,100 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.94 |
Taxes
In the past 12 months, STERIS has paid $114.43 million in taxes.
| Income Tax | 114.43M |
| Effective Tax Rate | 16.80% |
Stock Price Statistics
The stock price has increased by +7.15% in the last 52 weeks. The beta is 0.79, so STERIS's price volatility has been lower than the market average.
| Beta (1Y) | 0.79 |
| 52-Week Price Change | +7.15% |
| 50-Day Moving Average | 223.10 |
| 200-Day Moving Average | 220.04 |
| Relative Strength Index (RSI) | 28.47 |
| Average Volume (30 Days) | 482,545 |
Short Selling Information
The latest short interest is 2.68 million, so 2.71% of the outstanding shares have been sold short.
| Short Interest | 2.68M |
| Short Previous Month | 2.46M |
| Short % of Shares Out | 2.71% |
| Short % of Float | 2.72% |
| Short Ratio (days to cover) | 6.27 |
Income Statement
In the last 12 months, STERIS had revenue of $5.41 billion and earned $566.84 million in profits. Earnings per share was $5.70.
| Revenue | 5.41B |
| Gross Profit | 2.36B |
| Operating Income | 816.30M |
| Pretax Income | 681.27M |
| Net Income | 566.84M |
| EBITDA | 1.39B |
| EBIT | 820.16M |
| Earnings Per Share (EPS) | $5.70 |
Balance Sheet
The company has $195.59 million in cash and $3.51 billion in debt, giving a net cash position of -$3.31 billion or -$33.53 per share.
| Cash & Cash Equivalents | 195.59M |
| Total Debt | 3.51B |
| Net Cash | -3.31B |
| Net Cash Per Share | -$33.53 |
| Equity / Book Value | 6.42B |
| Book Value Per Share | 64.92 |
| Working Capital | 1.31B |
Cash Flow
In the last 12 months, operating cash flow was $934.27 million and capital expenditures -$330.48 million, giving a free cash flow of $603.79 million.
| Operating Cash Flow | 934.27M |
| Capital Expenditures | -330.48M |
| Free Cash Flow | 603.79M |
| FCF Per Share | $6.11 |
Margins
Gross margin is 43.60%, with operating and profit margins of 15.10% and 10.48%.
| Gross Margin | 43.60% |
| Operating Margin | 15.10% |
| Pretax Margin | 12.60% |
| Profit Margin | 10.48% |
| EBITDA Margin | 25.76% |
| EBIT Margin | 15.17% |
| FCF Margin | 11.17% |
Dividends & Yields
This stock pays an annual dividend of $2.08, which amounts to a dividend yield of 1.04%.
| Dividend Per Share | $2.08 |
| Dividend Yield | 1.04% |
| Dividend Growth (YoY) | 10.33% |
| Years of Dividend Growth | 13 |
| Payout Ratio | 36.49% |
| Buyback Yield | 1.02% |
| Shareholder Yield | 2.06% |
| Earnings Yield | 2.86% |
| FCF Yield | 3.04% |
Analyst Forecast
The average price target for STERIS is $242.67, which is 20.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $242.67 |
| Price Target Difference | 20.79% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 3.49 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.49 |
| Piotroski F-Score | 6 |